Bliley PM
RE: Chemosol
Abstract
Discusses recent agreement of American Chemosol Corporation "to have carried out through the auspices of the tobacco industry the independent test of Chemosol." States updated protocol being developed by the reactivated subcommittee includes conditions required by "the technical representatives of the nine sponsoring companies" if testing is to go forward. Expresses concern that lack of adherence to outlined requirements will lead to an "invalid result." Indicates expectation of review and approval by "sponsoring representatives at an early date."
Fields
- Type
- Letter
- Author
- Wakeham, Helmut R. R., Ph.D. (PM R&D VP)Vice President and Director of Research & Development, Philip Morris
- Author (Organization)
- Philip Morris Research Center
- Recipient
- Austern, H.T.
Tobacco industry law firm. Was involved in organizing the Whitecoat Project.
Associated with CTR, used as an expert in the Mississippi case.
Document Images
i
PHILIP 'MORRIS
U.S.A.
RESEARCH CENTER: P.O. BOX 3D, RICHMOND, VIRGINIA 23206 TELEPHONE ~/03)275-8361
September 26, 1969
Mr. H. Thomas. Austern
Covington 8~ Burling
888 Sixteenth Street N.W.
Washington, D.C.. 20006
re: Chemosol
Dear Mr. Austern:
As you know, following the recent agreement to your letter of August I,
1967 by the American Chemosol Corporation to have carried out through
the auspices of the tobacco industry the independent test of Chemosol, I
was asked to bring together the representatives of the nine sponsoring
companies for the purpose of agreeing upon a technical program for the
test. Accordingly, I reactivated the subcommittee which had previously
dealt with the matter of a Chemosol test protocol to be fo!lowed by Hazle-
ton Laboratories, and requested this group to contact Hazleton and to up-
date the protocol.
The new. protocol was presented~ to the technical representatives of the
nine sponsoring companies at a meeting tn New York on September 10,
I969 at which time the representatives reviewed the protocol in the presence
of Mr. James Gargus of Hazleton Laboratories, and agreedl upon certain
modifications. At that time we had in hand the comments: submitted by you
tn writing through Mr. Allan Topoi, who was also present at the New York
meeting.
We then requested' the protocol subcommittee to revise the protocol in line
with the discussions in New York, and to resubmit it to the technical represen-
tatives, the plan being: that when we had had an opportunity to re-examine it,
we would attempt to obtain agreement and approval. ~.0000334,~1~
During this period [ have been in close contact with the subcommittee which
had a meeting on Monday, September I5, at Hazleton for the purpose of
revising the protocol according to our instructions. I understand that you
attended that meeting (unannounced) and that you made some rather strong
remarks about the effectiveness of the technical representatives in preparing
an adequate protocol.
BENSON& HEDGES PARLIAMENT PHILIP MORRIS MARLBORO PERSONNA BLADES CLARK GUM

Mr. H. Thomas Austern - 2 -
September 26, 1969
There are obviously some differences of opinion between you and the technical
representatives regarding the conditions under which this test can be properly
carried out. I wish to make clear to you a number of points on which the
technical representatives are unanimously agreed; and so that there will be
no misunderstanding on this score, I am outlining these points in writing, as
follows:
1. It is our firm opinion that unless we receive tn writing a certificate
or assurances from the Chemosol representatives who supervise
the cigaret preparation that the treatment has been applied properly,
and that the samples are valid samples for the purpose of testing the
Chemosol hypothesis, there isno point in continuing with the bioassay
tests. It is, therefore, necessary before any company can properly
set up the conditions for applying Chemosol to the test tobacco, that
the Chemosol representatives agree to this procedure and, in fact,
indicate in as much detail as possible the conditions of the tobacco
and the environment in which the application is to be made. There
is no doubt in our minds about the need for this kind of a preliminary
negotiation with the Chemosol representatives, since they have de-
clared in past documents the necessity for precise humidity control,
etc., if the treatment is to be successful.
2. It is also, in our opinion, necessary for a technical representative
from the industry to be present at the negotiations with Chemosol
regarding the conditions of Chemosol application, since there will
undoubtedly be questions of a technical nature coming up in the dis-
cussion which will need to be answered during those negotiations.
Some of their demands may not be technically feasible; and unnecessary
or impractical concessions made in the absence of technical advice may
be embarrass ing.
3, During the course of the tests~ by Hazleton the work must be followed
by a technical liaison representative of the industry. The industry
representative must be able to certify at the end that Hazleton has
followed the requirements of the protocol, and has employed, adequate
quality control measures in the course of the tests. It is not enough
simply to receive an invoice at regular intervals from Hazleton as an
indication of their progress. The monitoring of the program by a tech-
nical representative is just good business practice and should be follow
ed in this case. ~.00003~459
We hope that you will see fit to keep these points in mind in your considerations
of the Chemosol test program. As you. know, there are many factors which can
go astray in the course of the test, factors which are vital to the success of the
test in terms of giving a valid result, and we need to follow this path very care-
fully.

Mr. H. Thomas Austern
- 3 - September 26, 1969
The protocol subgroup is well along with the description of how the cigaret
samples are to be prepared. We fully expect this and the revised bioassay
protocol to be reviewed and approved by the sponsoring representatives at
an early date.
Sincerely yours,
H " Wakeham, Vice President
Corporate Research and Development
cc: Mr. E. S. Harlow
Dr. A. W. Spears
Dr. W. W. Bates
Dr. R. A. Sanford
Dr. E. Nielson
Mr. W. B. Bennett
Mr. N. R. Gregory
Mr. J. Wood
Dr. M. Senkus
